Skip to main content
. 2018 Dec 21;19(3):1543–1550. doi: 10.3892/mmr.2018.9787

Figure 5.

Figure 5.

miR-219 inhibits the expression of pro-fibrotic markers and the fibrosis level in a chronic mouse liver injury model. The miRNA-219 agonist was delivered by tail vein injection in the model mice. The mRNA expression of (A) collagen type I and (B) collagen type III was downregulated in liver tissue following miR-219 treatment. (C) H&E and Masson staining of liver tissues in mice. One-way analysis of variance was used in A and B. **P<0.01 vs. sham. miR, microRNA; H&E, hematoxylin and eosin (scale bar, 25 µm).